Who we are


PlantArcBio is a public Ag-Bio company [TASE: PLNT], with an innovative and IP protected Direct-In-Plant (DIP™) discovery platform; with our platform, we discover & develop novel genes that has positive effects on plants, such as yield improvement, drought resistance and herbicide & insects tolerance. We license our genes to large seeds and crop protection companies. Among our strategic collaborators are ICL, KWS, Rallis, Gadot Agro,  Seach Medical Group, Bioceres, TMG and more.

Our DIP™ platform allows scanning of millions of genes, at once and at scale, directly on plants, so it makes gene discovery more effective and efficient than ever before. Leveraging our platform, we can now address any gene-pool from any source and test millions of genes directly in planta, to select best performing plants for any given trait. For example, We collected soil samples from the desert to identify best genes for drought resistant for plants

Following the gene discovery stage, we leverage the genes found to create positive effects on plants using Genetic Modification, Gene Editing and RNAi technologies, for seeds improvement and for external applications (RNAi sprays) for yield increase and crop protection.

We filed patents on our discovery platform and on all discoveries.

Board of Directors

Prof. Oded Shoseyov

Chairman Hebrew

Shmoulik Barash

Partner at Fortissimo
Capital Group

micha dazinger

Owner at Danzinger

Dr. Dror Shalitin

Founder and CEO at PlantArcBio

amichay rab (cPA)

CFO at Seach Medical Group

avi zigelman (CPA)

Experienced board member

ofra yamin (CPA)

Experienced board member